TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention January 21, 2011
TCL Archive The 99th turned Out Well For Cancer Program, But Several Important Issues Await 100th Congress October 31, 1986